QED Connect Inc. Completes Filings, Growing First Marijuana Harvest

QED Connect Inc. Completes Filings, Growing First Marijuana Harvest
  
 

MANCHESTER, NH--(Marketwired - Jun 4, 2014) - Management of QED Connect, Inc. (OTC Pink: QEDN) (PINKSHEETS: QEDN) today announced that they completed its filings for its year end 2013 and the first quarter 2014 to be in full compliance with its disclosures and financials as required by the OTC Markets guidelines. QED's status on OTC Markets is now listed as OTC Pink Current Information. 

Currently, the Company's wholly owned subsidiary, Emerald Med Farms LLC, has a marijuana crop in the process of maturing that is expected to be ready within the next 30 to 45 days for harvesting. The current crop is estimated to yield between 3 and 4 pounds per plant and, upon the successful harvesting of these strains of marijuana, the product will be distributed through a Cooperative of California medical dispensaries. 

The marijuana plants are from two strains: 1) The OG Kush Strain which was originally from Northern California and has quickly become known around the world for its distinct aroma and strong effects. The OG Kush strain is one of the most popular medical marijuana strains grown and sold by dispensaries today. 2) Sour Diesel Strain which is named after its pungent, diesel-like aroma. This fast-acting strain delivers energizing, dreamy cerebral effects that provides stress, pain, and depression relief and provides long-lasting relief making it a top choice among medical patients.

Steven Amato, Sr., General Manager and VP Operations of Emerald Med Farms, commented, "We are thrilled to be seeing our business plan come to life and, with the harvesting of the initial crop, be in position to complete its first phase. This is a very exciting time in the medical marijuana industry as it is continuing to evolve and, potentially, be accepted in all 50 states. How and what is being produced will probably become regulated much as the alcohol and cigarette industry. This will most likely require meeting approved standards for the method of growing and preparation of the marijuana. Emerald Med Farms is committed to be a leading provider of top quality cannabis plants and will be investing in the development of new and improved strains."

Please see the company's web site for additional information: www.emeraldmedfarms.com 

About QED Connect, Inc. QED Connect, Inc. is a holding company which makes acquisitions, investments, and enters into strategic business partnerships. The Company works with organizations that are looking for capital, management assistance, or help in reaching their target markets to realize their true potential. QED acquired StockProfile.com. In April 2014, the Company entered into an agreement to acquire Emerald Med Farms, LLC; a California based medical marijuana company. www.emeraldmedfarms.com . QED's business model helps to achieve its goals by expanding its overall revenue and profits potential through multiple market segments. www.qedconnect.com

Safe Harbor Statement Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of QED to be materially different from those expressed or implied by such forward-looking statements. QED's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors. 

For more information contact: Tom Makmann Tel: [phone] Fax: [phone] Email: [e-mail]